Ascletis Pharma Past Performance

How has Ascletis Pharma performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-44.3%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 1672 is currently unprofitable.

Growing Profit Margin: 1672 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 1672 is unprofitable, and losses have increased over the past 5 years at a rate of 44.3% per year.

Accelerating Growth: Unable to compare 1672's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 1672 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-7.7%).


Return on Equity

High ROE: 1672 has a negative Return on Equity (-6.49%), as it is currently unprofitable.


Discover strong past performing companies